STOCK TITAN

InMode Announces New Share Repurchase Program

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
buybacks

InMode (Nasdaq: INMD) on March 13, 2026 authorized a new share repurchase program for up to approximately 10% of shares outstanding (about 6.38 million ordinary shares). The company said it repurchased roughly $127.4 million of shares in 2025 and expects to fund repurchases with available cash.

Repurchases may occur in the open market or by other permitted means, are subject to market and legal conditions, and the program may be modified, suspended, or discontinued at the company's discretion.

Loading...
Loading translation...

Positive

  • Authorized buyback up to 10% (~6.38 million shares)
  • Repurchased $127.4 million of shares in 2025
  • Repurchases to be funded with available cash, per the company

Negative

  • Program may be modified, suspended, or discontinued at any time
  • Repurchases are subject to market conditions and legal requirements

Key Figures

New buyback size: up to ~10% of shares New buyback shares: approximately 6.38 million shares 2025 repurchases: $127.4 million
3 metrics
New buyback size up to ~10% of shares New repurchase program authorization
New buyback shares approximately 6.38 million shares Maximum ordinary shares under new program
2025 repurchases $127.4 million Shares repurchased in 2025 through prior programs

Market Reality Check

Price: $13.54 Vol: Volume 1,356,351 vs 20-da...
normal vol
$13.54 Last Close
Volume Volume 1,356,351 vs 20-day average 912,231 (relative 1.49x). normal
Technical Price $12.76 is trading below the $14.55 200-day moving average and near the 52-week low of $12.72.

Peers on Argus

INMD shows a pre-news decline of -2.89% while device peers are mixed: IRMD up 0....
1 Up

INMD shows a pre-news decline of -2.89% while device peers are mixed: IRMD up 0.74%, IART down 2.03%, TNDM down 2.95%, BBNX down 4.08%, SSII down 0.6%. Momentum scanner only flagged AHCO up 1.23%, suggesting stock-specific drivers rather than a broad sector move.

Previous Buybacks Reports

1 past event · Latest: Sep 10 (Positive)
Same Type Pattern 1 events
Date Event Sentiment Move Catalyst
Sep 10 Share repurchase Positive +8.8% New repurchase program of up to 7.68M shares funded with cash.
Pattern Detected

Prior buyback news on Sep 10, 2024 coincided with a positive +8.83% next-day move, indicating historically favorable reactions to repurchase announcements.

Recent Company History

This announcement follows an earlier buyback communication on Sep 10, 2024, when InMode authorized a share repurchase program of up to 7.68 million shares, funded with available cash and framed as a reflection of confidence in its long-term outlook. That prior buyback headline saw a +8.83% 24-hour price reaction. Today’s new program, again funded with cash and focused on capital allocation, extends this pattern of returning capital to shareholders.

Historical Comparison

+8.8% avg move · Over the past 18 months, INMD reported one prior buyback announcement, linked to a +8.83% move. The ...
buybacks
+8.8%
Average Historical Move buybacks

Over the past 18 months, INMD reported one prior buyback announcement, linked to a +8.83% move. The new repurchase program continues this capital-return theme against similar cash-rich conditions.

The company has progressed from a 2024 repurchase authorization of up to 7.68 million shares to a new 2026 program targeting up to roughly 10% of shares outstanding, again funded with available cash.

Market Pulse Summary

This announcement details a new share repurchase program for up to roughly 10% of InMode’s outstandi...
Analysis

This announcement details a new share repurchase program for up to roughly 10% of InMode’s outstanding shares, or about 6.38 million ordinary shares, funded entirely with available cash. It builds on prior repurchases of $127.4 million in 2025 and continues a capital-return focus. Investors may monitor how quickly the authorization is used, any changes in future buyback plans, and how this fits alongside growth investments amid macro and regional uncertainties.

Key Terms

share repurchase program
1 terms
share repurchase program financial
"announced that its Board of Directors has authorized a new share repurchase program"
A share repurchase program is when a company buys back its own shares from the marketplace. This reduces the total number of shares available, which can increase the value of each remaining share and signal confidence in the company's prospects. For investors, it often suggests that the company believes its stock is undervalued or that it has extra cash to return to shareholders.

AI-generated analysis. Not financial advice.

YOKNEAM, Israel, March 13, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that its Board of Directors has authorized a new share repurchase program for up to approximately 10% of the Company's total shares outstanding, representing approximately 6.38 million ordinary shares.

In 2025, the Company repurchased approximately $127.4 million of its outstanding ordinary shares through share repurchase programs. Despite a challenging macroeconomic environment, the Company continues to generate strong cash flow and believes that repurchasing shares at its current valuation represents an attractive use of capital.

While management remains focused on navigating the ongoing regional conflict and maintaining a disciplined approach to capital allocation, the Company will continue to evaluate additional share repurchase programs and other capital allocation opportunities going forward.

The Company expects to fund repurchases under the program with available cash. Repurchases may be made from time to time in the open market or through other permitted means, subject to market conditions and applicable legal requirements. The program may be modified, suspended, or discontinued at any time at the Company's discretion.

About InMode

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com/.

Forward-Looking Statements

The information in this press release includes forward-looking statements within the meaning of the federal securities laws. These statements generally relate to future events or InMode's future financial or operating performance, including the actual amount of share repurchases made by the Company, if any. Actual outcomes and results may differ materially from what is expressed or forecast in such forward-looking statements. In some cases, you can identify these statements because they contain words such as "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "predict," "project," "will," "would" and similar expressions that concern our expectations, strategic plans or intentions. Forward-looking statements are based on management's current expectations and assumptions, and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Consequently, actual results could differ materially from those indicated in these forward-looking statements. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements included in InMode's Annual Report on Form 20-F filed with the Securities and Exchange Commission on February 10, 2026, and our subsequent public filings. InMode undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. You are cautioned not to place undue reliance on these forward-looking statements, which pertain only as of the date of this press release.

Company Contact:

Yair Malca

Chief Financial Officer

Phone: (949) 305-0108

Email: Yair.Malca@inmodemd.com

Investor Relations Contact      

Miri Segal

MS-IR LLC

Email: ir@inmodemd.com

Logo - https://mma.prnewswire.com/media/1064477/5862039/InMode_Logo.jpg

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/inmode-announces-new-share-repurchase-program-302712849.html

SOURCE InMode Ltd.

FAQ

What is InMode's March 13, 2026 buyback program for INMD?

The program authorizes repurchasing up to 10% of shares outstanding (about 6.38 million shares). According to the company, repurchases may occur in the open market or by other permitted means and are subject to legal and market conditions.

How will InMode (INMD) fund the new repurchase program?

InMode expects to fund repurchases with available cash, the company said. This indicates the program will use on‑hand cash rather than issuing new debt, subject to ongoing cash flow and liquidity needs.

How much did InMode repurchase in 2025 before the 2026 program?

In 2025, InMode repurchased approximately $127.4 million of its ordinary shares. According to the company, that prior activity is cited as context for the newly authorized 2026 repurchase program.

Can InMode (INMD) stop or change the March 2026 buyback program?

Yes. The company said the program may be modified, suspended, or discontinued at any time. Repurchase timing and size will depend on market conditions and applicable legal requirements.

Will the INMD buyback definitely reduce share count immediately?

Not necessarily; repurchases will occur from time to time in the open market or by other permitted means. According to the company, actual reductions depend on timing, market conditions, and execution choices.
Inmode Ltd.

NASDAQ:INMD

View INMD Stock Overview

INMD Rankings

INMD Latest News

INMD Latest SEC Filings

INMD Stock Data

808.46M
56.53M
Medical Devices
Healthcare
Link
Israel
Yokne'am